Why is this study important? GLP-1 medications have traditionally been off-limits for people with type 1 diabetes due to concerns around risks like hypoglycemia and diabetic ketoacidosis (DKA). That ...

Exercise snacks – short bursts of physical activity – can improve glycemic control and boost cardiovascular fitness. Experts share tips on how to incorporate exercise snacks into your daily routine.

Nausea and stomach problems are well-known side effects of GLP-1s, but you may be less familiar with other pros and cons of these powerful medications. With more and more people using GLP-1 receptor ...

Grains are an excellent source of fiber and other vital nutrients, but which are best for diabetes? Here's why nutritious options like farro, oats, and quinoa are at the top of the list. You’ve heard ...

The daily pill Rezdiffra is the first treatment for people with a type of liver disease known as MASH, which affects up to 20% of people with type 2 diabetes. Rezdiffra’s FDA approval marks a historic ...

Continuous glucose monitoring (CGM) can dramatically improve glucose management – but these devices can also bring their own set of challenges, especially if you have sensitive skin. Luckily, there ...

Thyroid disease can occur with type 1 diabetes and cause symptoms such as fatigue and temperature sensitivity. It’s not uncommon for people with one autoimmune disease to develop other autoimmune ...

While continuous glucose monitors are part of routine care for people with type 1 diabetes, there are many other people who may also benefit from real-time insight into glucose levels. Experts ...

Many people with diabetes – even those using the latest technology – struggle with high blood sugar after eating. We spoke with experts for tips on how to minimize those stubborn glucose spikes. We’ve ...

Recent integrations between continuous glucose monitors and insulin pumps are allowing diabetes tech users to choose between more options. Tandem t:slim X2 users can now use either the FreeStyle Libre ...

Clinical trial participants taking survodutide for obesity experienced up to 19% in weight loss over 46 weeks in the latest research presented at the 2023 EASD Conference in Hamburg, Germany. An ...

Tirzepatide (sold as Mounjaro) is more effective than semaglutide (Ozempic) for both blood glucose control and weight loss, according to a new analysis. The diabetes drug tirzepatide (brand name ...